1-3 of 3
Young J. Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer

Aleksandar Obradovic, Diana Graves, Michael Korrer, Yu Wang, Sohini Roy, Abdullah Naveed, Yaomin Xu, Adam Luginbuhl, Joseph Curry, Michael Gibson, Kamran Idrees, Paula Hurley, Peng Jiang, X. Shirley Liu, Ravindra Uppaluri, Charles G. Drake, Andrea Califano, Young J. Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2094–2109.
https://doi.org/10.1158/1078-0432.CCR-21-3570
Published: 13 May 2022
View article titled, Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Open the PDF for Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

Adam J. Luginbuhl, Jennifer M. Johnson, Larry A. Harshyne, Alban J. Linnenbach, Sanket K. Shukla, Angela Alnemri, Gaurav Kumar, David M. Cognetti, Joseph M. Curry, Nikita Kotlov, Zoya Antysheva, Sandrine Degryse, Kyle Mannion, Michael K. Gibson, James Netterville, Brandee Brown, Rita Axelrod, Ralph Zinner, Madalina Tuluc, Stacey Gargano, Benjamin E. Leiby, Ayako Shimada, My G. Mahoney, Ubaldo Martinez-Outschoorn, Ulrich Rodeck, Young J. Kim, Andrew P. South, Athanassios Argiris
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 915–927.
https://doi.org/10.1158/1078-0432.CCR-21-1816
Published: 01 March 2022
View article titled, Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
Open the PDF for Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses

Meghan B. Davis, David Vasquez-Dunddel, Juan Fu, Emilia Albesiano, Drew Pardoll, Young J. Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 3984–3992.
https://doi.org/10.1158/1078-0432.CCR-10-3262
Published: 15 June 2011
View article titled, Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
Open the PDF for Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses in another window
Includes: Supplementary data